Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.
Brand protection and customer connection solutions company YPB Group Ltd (ASX:YPB) and life sciences company Cellmid Limited (ASX:CDY) have signed an agreement to utilise the YPB CONNECT Consumer Connection SaaS platform in the marketing of Cellmid's evolis(R) hair loss products in China.
The Board of Queensland Bauxite (ASX:QBL), is anticipating that the successful launch of these premium all-Australian products, will generate significant cashflow for the Company in 2018, and enable dividends for shareholders.
The Board of Queensland Bauxite (ASX:QBL) considers that a monumental milestone has been reached by Medical Cannabis Limited, QBL's Hemp Seed Food production and medicinal Cannabis investment company.
At the Australasian Pig Science Association Conference in Melbourne this week, Dr Trish Holyoake & Dr Tracey Mynott presented a poster highlighting the comparable efficacy of a single dose of Anatara's (ASX:ANR) Detach(R) product to in-feed Zinc oxide in reducing diarrhoea and antibiotic treatments in post-weaning piglets.
A significant milestone has now been reached in Australia that has a major positive impact on the potential business, cashflow and profitability for Queensland Bauxite Limited's (ASX:QBL) investment in Medical Cannabis Limited.
Anatara Lifesciences Ltd (ASX:ANR) provides the Chairman's address to shareholders.
